A scientist with an entrepreneurial edge, Dr. Shalini Prasad innovations include a rapid fentanyl detection system, a DIY food safety tester, and a wearable healthcare monitor—each designed to give users critical, real-time information. [Photo: UTD}
Combining cutting-edge research and real-world applications, the UT Dallas professor transforms public health with innovations in detection technology, including “a check engine light” for the human body. In collaboration with EnLiSense, the company she cofounded, Dr. Prasad combines chemistry with software and hardware to bring the technology to life as market-ready devices.
TI says its Hall-effect sensor is "the industry's most accurate." The 3D-sensing technology is a boon for smart factories and the real-time control of devices like autonomous robots.
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Electric mobility is about more than battery range now. As EVs become part of everyday life, people want the experience to feel simple and reassuring, whether they are finding a charger, checking their vehicle status, making a payment, or getting help when they need it....
Plano-based Secretome Therapeutics, a biotech company advancing therapies derived from neonatal cardiac progenitor cells (nCPC), has announced the closing of $30 million in Series A financing from RA Capital Management, a multi-stage investment manager focused on public and private healthcare, life sciences, and planetary health companies....
“It’s critical that we increase awareness of the high prevalence of Alzheimer’s disease among adults with Down syndrome… ”
Melissa Petersen, Ph.D.
Associate Professor UNT Health Fort Worth
.…on being UNT Health’s lead scientific investigator for the Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) study....
UNT Health Fort Worth’s Institute for Translational Research is set to become the first site in Texas to join a national study on Alzheimer’s disease in adults with Down syndrome.
The Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) study, a national research initiative supported by the National Institutes of Health, studies how Alzheimer’s disease develops in adults with Down syndrome and aims to identify early biological markers of the disease....
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Electric mobility is about more than battery range now. As EVs become part of everyday life, people want the experience to feel simple and reassuring, whether they are finding a charger, checking their vehicle status, making a payment, or getting help when they need it....
Plano-based Secretome Therapeutics, a biotech company advancing therapies derived from neonatal cardiac progenitor cells (nCPC), has announced the closing of $30 million in Series A financing from RA Capital Management, a multi-stage investment manager focused on public and private healthcare, life sciences, and planetary health companies....
“It’s critical that we increase awareness of the high prevalence of Alzheimer’s disease among adults with Down syndrome… ”
Melissa Petersen, Ph.D.
Associate Professor UNT Health Fort Worth
.…on being UNT Health’s lead scientific investigator for the Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) study....
UNT Health Fort Worth’s Institute for Translational Research is set to become the first site in Texas to join a national study on Alzheimer’s disease in adults with Down syndrome.
The Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) study, a national research initiative supported by the National Institutes of Health, studies how Alzheimer’s disease develops in adults with Down syndrome and aims to identify early biological markers of the disease....